肺部微生物群:治疗急性呼吸系统应急综合征的新希望?
1Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Frontiers in microbiology
|June 16, 2025
概括
改变的肺微生物群会影响免疫力和疾病,特别是在急性呼吸困扰综合征 (ARDS) 中. 了解这些微生物转变为ARDS患者提供了潜在的新疗法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 肺部微生物群影响免疫反应和疾病的发展.
- 急性呼吸窘迫综合征 (ARDS) 是一种严重的肺部疾病,死亡率高.
- ARDS涉及复杂的炎症,伤害和凝血路径.
研究的目的:
- 审查肺微生物群在ARDS中的调节作用.
- 探索针对ARDS肺部微生物群的治疗潜力.
主要方法:
- 对肺部微生物群和ARDS研究的文献综述.
- 对ARDS病原发生过程中的微生物变异现有证据的分析.
主要成果:
- 肺部微生物群的变化,包括增加的细菌负载和减少的多样性,与ARDS的发展有关.
- 微生物群的改变可能有助于ARDS复杂的病理生理学.
结论:
- 肺部微生物群在ARDS的发病过程中起着重要作用.
- 调节肺部微生物群为ARDS提供了一个有希望的治疗途径.
更多相关视频
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
540
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
11.0K
相关概念视频
01:29Acute Respiratory Failure-V
216
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
216
01:28Pneumonia IV: Management
458
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
458